Skip to main content
. 2022 Feb 24;14(5):1166. doi: 10.3390/cancers14051166

Table 5.

Events after treatment.

Event SBRT (n = 95) CCRT (n = 66) p Value
Curative resection 7 (7.4%) 2 (3.0%) 0.311
* Treatment-related toxicity (≥Grade 3)
 Acute 3 (3.2%) 5 (7.6%) 0.274
 Late 2 (2.1%) 1 (1.5%) 1.000
First site of treatment failure 79 (83.2%) 56 (84.8%) 0.102
 Local 12 (12.6%) 17 (25.8%) -
 Distant 55 (57.9%) 31 (47.0%) -
 Both 12 (12.6%) 8 (12.1%) -

Abbreviations: SBRT, stereotactic body radiotherapy; CCRT, concurrent chemoradiotherapy. * Toxicity was assessed using Common Terminology Criteria for Adverse Events, version 4.0 (https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm, accessed on 23 February 2022). Events reported within 90 days after RT were classified as acute toxicities, whereas those occurring after 90 days were considered as late toxicities.